The treatment approaches for lung cancer are rapidly evolving, and include integration of new systemic therapies (e.g. immunotherapy and targeted therapies) into combined modality approaches for non-metastatic disease and ablative radiation therapy approaches for oligo-metastatic disease.

The treatment approaches for lung cancer are rapidly evolving, and include integration of new systemic therapies (e.g. immunotherapy and targeted therapies) into combined modality approaches for non-metastatic disease and ablative radiation therapy approaches for oligo-metastatic disease.

This course is designed to provide clinicians in practice and trainees with a comprehensive review and update of the clinical practice parameters across most major sub-disciplines of radiation oncology, including sarcomas, pediatrics and lymphomas, and the role of radiotherapy in the multidiscipl

Q&A Session for Sarcomas and Head and Neck with Meena Pedi, MD, and Sue Yom, MD.

This is a lecture-based educational format designed to update attendees on the latest evidence-based practice recommendations for head and neck cancer radiation therapy.

Soft tissue sarcomas are rare and involve a well-integrated multimodality approach to optimize outcomes and decrease morbidity.

Q&A Session for Genitourinary, PET Guided Radiotherapy and Oligomets/SBRT with Rahul Tendulkar, MD, Murat Surucu, PhD, and David Palma, MD, PhD.

The purpose of this educational lecture will be to review recent data on treatment of oligometastases, and to discuss practical approaches to treatment at different locations.

In this activity, the components of this novel PET/Linac will be introduced to the audience. The highlights of the commissioning and clinical implementation of this linac using IMRT/SBRT mode will be discussed. The unique challenges of BgRT workflow and use cases will be discussed.